- Nachrichtendetail
-
27.09.2023 15:02:42 - dpa-AFX: *NEKTAR,CELLULAR BIOMEDICINE TO EVALUATE NKTR-255 IN COMBINATION WITH C-TIL051 IN ADVANCED NON-SMALL CELL LUNG CANCER
Copyright(c) 2023 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
NEKTAR THERAPEUTICS | 165417 | Frankfurt | 1,590 | 23.05.24 08:08:56 | +0,051 | +3,31% | 1,575 | 1,630 | 1,590 | 1,539 |
